Eton Pharmaceuticals Announces Addition to Russell 2000® and Russell 3000® Indexes

DEER PARK, Ill., June 27, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it will be added to the broad-market Russell 3000^® and small-cap Russell 2000^® Indexes, effective after the U.S. market closes on June 27, as part of the 2025 Russell Indexes reconstitution.

Read more at globenewswire.com